Agribusiness giant Monsanto MON has lost almost two-thirds of its value since its 2008 high. According to Barron’s, the stock is among the worst-performing equities in the Standard & Poor’s 500 this year.
However, Robert Koort, an equity analyst with Goldman Sachs GS, told Barron’s, “We believe the bad news is exhausted.” The stock gained 3% following the endorsement. Barron’s further claimed that it had endorsed the stock a lot earlier.
Monsanto (MON), on the other hand, has drastically curtailed its 2010 EPS guidance to $2.40-$2.60 from $3.10 and $3.30.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorAnalyst RatingsBarron'sFertilizers & Agricultural ChemicalsFinancialsGoldman SachsInvestment Banking & BrokerageMaterialsRobert Koort
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in